| Net income (loss) | |
| Depreciation and amortization | 409.23K |
| Fair value of common stock issued to consultants | 34K |
| Fair value of extension in term of warrants issued to noteholders | |
| Fair value of stock options vested by officers and directors | 1.03M |
| Amortization of discount on notes payable | 277.53K |
| Amortization of discounts on accrued convertible interest | |
| Gain on extinguishment of debt | |
| Allowance for bad debt | 11.96K |
| Change in fair value of warrant liability | |
| Change in fair value of option liability | |
| Change in fair value of conversion option liability | |
| Accounts receivable | -237.27K |
| Inventory and other current assets, net | |
| Accrued liability and accrued interest - related party, net | |
| Accounts payable and accrued interest | 197.6K |
| Net cash provided by operating activities | 1.56M |
| Principal payments received on loan | |
| Purchase of treasury stock | -14.85K |
| Acquisition of property and equipment | -10.51K |
| Net cash used in investing activities | -480.99K |
| Principal payments on debt – related parties | |
| Principal payments on debt | |
| Net cash used in financing activities | -1.08M |
| Net increase in cash and cash equivalents | 1.81K |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period | |
| Interest | 96.32K |
| Taxes | 0 |
| Conversion of notes payable and accrued interest to common stock | |
| Conversion of notes payable and accrued interest to common stock subscribed | |